---
title: "Bayesian Statistics, Metabolomics & Covid-19"
author: "Novia Minaee"
date: "15/04/2021"
output:
  ioslides_presentation: default
  beamer_presentation: default
bibliography: /Users/novia/Documents/novia/novia_ref.bib
---

```{r setup, include=FALSE}
knitr::opts_chunk$set(echo = FALSE)
```

 
<style>
div.footnotes {
  position: absolute;
  bottom: 0;
  margin-bottom: 10px;
  width: 80%;
  font-size: 0.6em;
}
</style>
 
<script src="https://ajax.googleapis.com/ajax/libs/jquery/3.1.1/jquery.min.js"></script>
 
<script>
  $(document).ready(function() {
    $('slide:not(.backdrop):not(.title-slide)').append('<div class=\"footnotes\">');
 
    $('footnote').each(function(index) {
      var text  = $(this).html();
      var fnNum = (index+1).toString().sup();
      $(this).html(text + fnNum);
 
      var footnote   = fnNum + ': ' + $(this).attr('content') + '<br/>';
      var oldContent = $(this).parents('slide').children('div.footnotes').html();
      var newContent = oldContent + footnote;
      $(this).parents('slide').children('div.footnotes').html(newContent);
    });
  });
</script>


## COVID-19 pandemic <font size="5">

According to World Health Organization <footnote content="As per 7th April 2021"></footnote>: 

- Caused by severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)
- Has spread to 223 countries
- Infected > 133.5 million people
- Killed > 2.8 million people

</font>


## COVID-19 symptoms <font size="5">

- Every individual responses differently to the virus
- Most individuals experience mild sore throat, fever and fatigue
- A subset of individuals experience severe respiratory distress, organ failure and cytokine storm that results in death [@ayres2020metabolic; @kimhofer2020integrative]

</font>


## COVID-19 and metabolic pathway <font size="4">

* Several common metabolic pathways were found to be significantly perturbed in COVID-19 patients [@pang2021comprehensive]: 

  - Porphyrin 
  - Cellular amino acidarachidonic acid


* Others were found to be associated with the progression and severity of COVID-19 [@pang2021comprehensive; @polonikov2020endogenous; @li2020insight]: 

  - Propanate
  - TCA
  - Selenocompound
  - Mannose
  - Glutathione 

</font>

## Statistical methods in metabolomics <font size="5">

The most common statistical methods used to analyse metabolomics data are [@gromski2015tutorial; @ren2015computational; @lee2018partial]: 

- Principal component analysis (PCA) - unsupervised 
- Partial least squares-discriminant analysis (PLS-DA) - supervised 
- Orthogonal projections to latent structures-discriminant analysis (OPLS-DA) - supervised  

</font>


## Limitations to PCA <font size="5">

PCA [@ren2015computational; @blasco2015comparative] : 

- Prone to outliers
- The groups that are shown in the PCA scores plot are not necessarily the biologically meaningful groups. 
- PCA only works if the first few PCs can explain a large proportion of the variability. Otherwise, the visualisation results may be misleading. 

</font>

## Limitations to PLS-DA <font size="4">

PLS-DA [@gromski2015tutorial; @ren2015computational; @lee2018partial; @brereton2014partial; @blasco2015comparative]

- Does not handle missing values well
- Issues with fitting when p >> n
- Does not incorporate pathway information 
- Can not incorporate individual level of information
  - Every individual responses differently to COVID-19
  - Each immune system relies on multiple metabolic pathways to initiate and regulate response to COVID-19
  - It is extremely important to take these individual level's information and pathways information into account when conducting a statistical analysis. 

</font> 
 
## Bayesian Statistics <font size="4">

* One approach that would allow the incorporation of individual information is Bayesian statistics. 

* Bayesian statistics began when **Bayes theorem** was first postulated by The Rev Thomas Bayes in 1763 [@bayes1763lii].  

\[p\left(\theta\mid x\right)\propto p\left(x\mid\theta\right) 
\]

* In other words, the computation of the posterior requires three terms: 

  - a prior: $p\left(\theta\right)$ 
  - a likelihood: $p\left(x\mid\theta\right)$ 
  - an observation: $p\left(x\mid\theta\right)$

</font>


## Bayesian workflow <font size=5">

A typical Bayesian workflow have three main aspects: 

1. capturing pre-existing knowledge about a given parameter in a statistical model via the formulation of **prior distribution**.
2. determining the **likelihood function** of the parameters using the observed data
3. combining both the **prior distribution** and the **likelihood function** using Bayes theorem in the form of the **posterior distribution**. 

 </font>


## Bayesian workflow [@van2021bayesian]

```{r out.width = "65%"}
library(knitr)
include_graphics("/Users/novia/Documents/novia/figure/bayes_workflow.png")
```


## Hierarchical Bayesian Model (HBM) <font size="4">

- It is a multi-level Bayesian modeling which enables us to make scientific inferences about a population based on many individuals (or observations).

- It allows the incorporation of pathway information as a 'grouping' mechanism in the model hierarchy. 

- It allows the incorporation of each unique individual as a 'grouping' mechanism in the model hierarchy. 

</font>


## Parameter estimation <font size="3">

We start with our regular Bayesian parameter estimation:

\[
P\left(\varTheta_{i}\mid X_{i}\right)=\frac{P\left(X_{i}\mid\varTheta_{i}\right)}{P\left(X_{i}\right)}=\frac{P\left(X_{i}\mid\varTheta_{i}\right)P\left(\varTheta_{i}\right)}{\int P\left(X_{i}\mid\varTheta_{i'}\right)P\left(\varTheta_{i'}\right)d\varTheta_{i}'}
\]

  - $X_{i}$ = the observation
  - $\varTheta_{i}$ = a set of parameters of a model for individual *i* 
  - $P(X_{i})$ = the likelihood of data being generated by this model
  - $P(\varTheta_{i})$ and $P(\varTheta_{i}\mid X_{i})$ = the prior and posterior distributions of $\varTheta_{i}$, respectively.


In HBM, hyper-parameters are introduced on top of individual parameters. If we set hyper-parameters as 
$\varPhi=\left\{ \mu_{\alpha},\mu_{\beta},\mu_{\gamma},\sigma_{\alpha},\sigma_{\beta},\sigma_{\gamma},\ldots\right\}$ with group-level normal means $\mu_{\left(\cdot\right)}$ and standard deviation $\sigma_{\left(\cdot\right)}$, the joint posterior distribution $P\left(\Theta,\Phi\mid X\right)$ is:

\[
P\left(\Theta,\Phi\mid X\right)=\frac{P\left(X\mid\Theta,\Phi\right)P\left(\Theta,\Phi\right)}{P\left(X\right)}\varpropto P\left(X\mid\Theta\right)P\left(\Theta\mid\Phi\right)P\left(\varPhi\right)
\]

</font>

## Shrinkage <font size="4">

The hierarchical structure of HBM leads to "shrinkage" effects [@anh2016hBayesDM] in individual estimates. 

In simple terms, when each individual's estimates inform the group's estimates, this action in turn inform the estimates of all individuals because the group's estimates 'control' the individuals' estimates. 

Consequently individual parameter estimates tend to be better because commonalities among individuals are captured and informed by group estimates. 


```{r out.width = "65%", fig.align='center'}
library(knitr)
include_graphics("/Users/novia/Documents/novia/figure/shrinkage.png")
```

</font>


## Applying Bayes 

<font size="4"> One of the pathway identified in metabolic pertubation due to COVID-19 is Tricarboxylic Acid (TCA). 

There are many metabolites in this pathway that can alter the response of both the innate and adaptive immune systems, for example: 

- acetyl-CoA
- itaconate
- succinate
- fumarate
- L-2-HG 

</font>


## TCA pathway

```{r out.width = "65%", fig.align='center'}
library(knitr)
include_graphics("/Users/novia/Documents/novia/figure/TCA-krebs-cycle.png")
```


## Incorporating TCA into COVID-19 model

<font size="4"> Below is a simple graph to illustrate a single pathway as a grouping variable sits atop the individual metabolites within that pathway. </font>

```{r out.width = "100%"}
library(knitr)
include_graphics("/Users/novia/Documents/novia/figure/tca_hier.png")
```


##
<div class="centered"><font size="20">
**Thank you for your attention**
</div></font>


## References
<font size="1">

